Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Motion Sickness Treatment Market, by Drug Class
1.4.2 Global Motion Sickness Treatment Market, by Route of Administration
1.4.3 Global Motion Sickness Treatment Market, by Distribution Channel
1.4.4 Global Motion Sickness Treatment Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Motion Sickness Treatment Market by Drug Class
3.1 Global Antihistamines Market by Region
3.2 Global Anticholinergics Market by Region
3.3 Global Others Market by Region
Chapter 4. Global Motion Sickness Treatment Market by Route of Administration
4.1 Global Oral Market by Region
4.2 Global Others Market by Region
Chapter 5. Global Motion Sickness Treatment Market by Distribution Channel
5.1 Global Drug Store & Retail Pharmacies Market by Region
5.2 Global Hospital Pharmacies Market by Region
5.3 Global Online Pharmacies Market by Region
Chapter 6. Global Motion Sickness Treatment Market by Region
6.1 North America Motion Sickness Treatment Market
6.1.1 North America Motion Sickness Treatment Market by Drug Class
6.1.1.1 North America Antihistamines Market by Country
6.1.1.2 North America Anticholinergics Market by Country
6.1.1.3 North America Others Market by Country
6.1.2 North America Motion Sickness Treatment Market by Route of Administration
6.1.2.1 North America Oral Market by Country
6.1.2.2 North America Others Market by Country
6.1.3 North America Motion Sickness Treatment Market by Distribution Channel
6.1.3.1 North America Drug Store & Retail Pharmacies Market by Country
6.1.3.2 North America Hospital Pharmacies Market by Country
6.1.3.3 North America Online Pharmacies Market by Country
6.1.4 North America Motion Sickness Treatment Market by Country
6.1.4.1 US Motion Sickness Treatment Market
6.1.4.1.1 US Motion Sickness Treatment Market by Drug Class
6.1.4.1.2 US Motion Sickness Treatment Market by Route of Administration
6.1.4.1.3 US Motion Sickness Treatment Market by Distribution Channel
6.1.4.2 Canada Motion Sickness Treatment Market
6.1.4.2.1 Canada Motion Sickness Treatment Market by Drug Class
6.1.4.2.2 Canada Motion Sickness Treatment Market by Route of Administration
6.1.4.2.3 Canada Motion Sickness Treatment Market by Distribution Channel
6.1.4.3 Mexico Motion Sickness Treatment Market
6.1.4.3.1 Mexico Motion Sickness Treatment Market by Drug Class
6.1.4.3.2 Mexico Motion Sickness Treatment Market by Route of Administration
6.1.4.3.3 Mexico Motion Sickness Treatment Market by Distribution Channel
6.1.4.4 Rest of North America Motion Sickness Treatment Market
6.1.4.4.1 Rest of North America Motion Sickness Treatment Market by Drug Class
6.1.4.4.2 Rest of North America Motion Sickness Treatment Market by Route of Administration
6.1.4.4.3 Rest of North America Motion Sickness Treatment Market by Distribution Channel
6.2 Europe Motion Sickness Treatment Market
6.2.1 Europe Motion Sickness Treatment Market by Drug Class
6.2.1.1 Europe Antihistamines Market by Country
6.2.1.2 Europe Anticholinergics Market by Country
6.2.1.3 Europe Others Market by Country
6.2.2 Europe Motion Sickness Treatment Market by Route of Administration
6.2.2.1 Europe Oral Market by Country
6.2.2.2 Europe Others Market by Country
6.2.3 Europe Motion Sickness Treatment Market by Distribution Channel
6.2.3.1 Europe Drug Store & Retail Pharmacies Market by Country
6.2.3.2 Europe Hospital Pharmacies Market by Country
6.2.3.3 Europe Online Pharmacies Market by Country
6.2.4 Europe Motion Sickness Treatment Market by Country
6.2.4.1 Germany Motion Sickness Treatment Market
6.2.4.1.1 Germany Motion Sickness Treatment Market by Drug Class
6.2.4.1.2 Germany Motion Sickness Treatment Market by Route of Administration
6.2.4.1.3 Germany Motion Sickness Treatment Market by Distribution Channel
6.2.4.2 UK Motion Sickness Treatment Market
6.2.4.2.1 UK Motion Sickness Treatment Market by Drug Class
6.2.4.2.2 UK Motion Sickness Treatment Market by Route of Administration
6.2.4.2.3 UK Motion Sickness Treatment Market by Distribution Channel
6.2.4.3 France Motion Sickness Treatment Market
6.2.4.3.1 France Motion Sickness Treatment Market by Drug Class
6.2.4.3.2 France Motion Sickness Treatment Market by Route of Administration
6.2.4.3.3 France Motion Sickness Treatment Market by Distribution Channel
6.2.4.4 Russia Motion Sickness Treatment Market
6.2.4.4.1 Russia Motion Sickness Treatment Market by Drug Class
6.2.4.4.2 Russia Motion Sickness Treatment Market by Route of Administration
6.2.4.4.3 Russia Motion Sickness Treatment Market by Distribution Channel
6.2.4.5 Spain Motion Sickness Treatment Market
6.2.4.5.1 Spain Motion Sickness Treatment Market by Drug Class
6.2.4.5.2 Spain Motion Sickness Treatment Market by Route of Administration
6.2.4.5.3 Spain Motion Sickness Treatment Market by Distribution Channel
6.2.4.6 Italy Motion Sickness Treatment Market
6.2.4.6.1 Italy Motion Sickness Treatment Market by Drug Class
6.2.4.6.2 Italy Motion Sickness Treatment Market by Route of Administration
6.2.4.6.3 Italy Motion Sickness Treatment Market by Distribution Channel
6.2.4.7 Rest of Europe Motion Sickness Treatment Market
6.2.4.7.1 Rest of Europe Motion Sickness Treatment Market by Drug Class
6.2.4.7.2 Rest of Europe Motion Sickness Treatment Market by Route of Administration
6.2.4.7.3 Rest of Europe Motion Sickness Treatment Market by Distribution Channel
6.3 Asia Pacific Motion Sickness Treatment Market
6.3.1 Asia Pacific Motion Sickness Treatment Market by Drug Class
6.3.1.1 Asia Pacific Antihistamines Market by Country
6.3.1.2 Asia Pacific Anticholinergics Market by Country
6.3.1.3 Asia Pacific Others Market by Country
6.3.2 Asia Pacific Motion Sickness Treatment Market by Route of Administration
6.3.2.1 Asia Pacific Oral Market by Country
6.3.2.2 Asia Pacific Others Market by Country
6.3.3 Asia Pacific Motion Sickness Treatment Market by Distribution Channel
6.3.3.1 Asia Pacific Drug Store & Retail Pharmacies Market by Country
6.3.3.2 Asia Pacific Hospital Pharmacies Market by Country
6.3.3.3 Asia Pacific Online Pharmacies Market by Country
6.3.4 Asia Pacific Motion Sickness Treatment Market by Country
6.3.4.1 China Motion Sickness Treatment Market
6.3.4.1.1 China Motion Sickness Treatment Market by Drug Class
6.3.4.1.2 China Motion Sickness Treatment Market by Route of Administration
6.3.4.1.3 China Motion Sickness Treatment Market by Distribution Channel
6.3.4.2 Japan Motion Sickness Treatment Market
6.3.4.2.1 Japan Motion Sickness Treatment Market by Drug Class
6.3.4.2.2 Japan Motion Sickness Treatment Market by Route of Administration
6.3.4.2.3 Japan Motion Sickness Treatment Market by Distribution Channel
6.3.4.3 India Motion Sickness Treatment Market
6.3.4.3.1 India Motion Sickness Treatment Market by Drug Class
6.3.4.3.2 India Motion Sickness Treatment Market by Route of Administration
6.3.4.3.3 India Motion Sickness Treatment Market by Distribution Channel
6.3.4.4 South Korea Motion Sickness Treatment Market
6.3.4.4.1 South Korea Motion Sickness Treatment Market by Drug Class
6.3.4.4.2 South Korea Motion Sickness Treatment Market by Route of Administration
6.3.4.4.3 South Korea Motion Sickness Treatment Market by Distribution Channel
6.3.4.5 Singapore Motion Sickness Treatment Market
6.3.4.5.1 Singapore Motion Sickness Treatment Market by Drug Class
6.3.4.5.2 Singapore Motion Sickness Treatment Market by Route of Administration
6.3.4.5.3 Singapore Motion Sickness Treatment Market by Distribution Channel
6.3.4.6 Malaysia Motion Sickness Treatment Market
6.3.4.6.1 Malaysia Motion Sickness Treatment Market by Drug Class
6.3.4.6.2 Malaysia Motion Sickness Treatment Market by Route of Administration
6.3.4.6.3 Malaysia Motion Sickness Treatment Market by Distribution Channel
6.3.4.7 Rest of Asia Pacific Motion Sickness Treatment Market
6.3.4.7.1 Rest of Asia Pacific Motion Sickness Treatment Market by Drug Class
6.3.4.7.2 Rest of Asia Pacific Motion Sickness Treatment Market by Route of Administration
6.3.4.7.3 Rest of Asia Pacific Motion Sickness Treatment Market by Distribution Channel
6.4 LAMEA Motion Sickness Treatment Market
6.4.1 LAMEA Motion Sickness Treatment Market by Drug Class
6.4.1.1 LAMEA Antihistamines Market by Country
6.4.1.2 LAMEA Anticholinergics Market by Country
6.4.1.3 LAMEA Others Market by Country
6.4.2 LAMEA Motion Sickness Treatment Market by Route of Administration
6.4.2.1 LAMEA Oral Market by Country
6.4.2.2 LAMEA Others Market by Country
6.4.3 LAMEA Motion Sickness Treatment Market by Distribution Channel
6.4.3.1 LAMEA Drug Store & Retail Pharmacies Market by Country
6.4.3.2 LAMEA Hospital Pharmacies Market by Country
6.4.3.3 LAMEA Online Pharmacies Market by Country
6.4.4 LAMEA Motion Sickness Treatment Market by Country
6.4.4.1 Brazil Motion Sickness Treatment Market
6.4.4.1.1 Brazil Motion Sickness Treatment Market by Drug Class
6.4.4.1.2 Brazil Motion Sickness Treatment Market by Route of Administration
6.4.4.1.3 Brazil Motion Sickness Treatment Market by Distribution Channel
6.4.4.2 Argentina Motion Sickness Treatment Market
6.4.4.2.1 Argentina Motion Sickness Treatment Market by Drug Class
6.4.4.2.2 Argentina Motion Sickness Treatment Market by Route of Administration
6.4.4.2.3 Argentina Motion Sickness Treatment Market by Distribution Channel
6.4.4.3 UAE Motion Sickness Treatment Market
6.4.4.3.1 UAE Motion Sickness Treatment Market by Drug Class
6.4.4.3.2 UAE Motion Sickness Treatment Market by Route of Administration
6.4.4.3.3 UAE Motion Sickness Treatment Market by Distribution Channel
6.4.4.4 Saudi Arabia Motion Sickness Treatment Market
6.4.4.4.1 Saudi Arabia Motion Sickness Treatment Market by Drug Class
6.4.4.4.2 Saudi Arabia Motion Sickness Treatment Market by Route of Administration
6.4.4.4.3 Saudi Arabia Motion Sickness Treatment Market by Distribution Channel
6.4.4.5 South Africa Motion Sickness Treatment Market
6.4.4.5.1 South Africa Motion Sickness Treatment Market by Drug Class
6.4.4.5.2 South Africa Motion Sickness Treatment Market by Route of Administration
6.4.4.5.3 South Africa Motion Sickness Treatment Market by Distribution Channel
6.4.4.6 Nigeria Motion Sickness Treatment Market
6.4.4.6.1 Nigeria Motion Sickness Treatment Market by Drug Class
6.4.4.6.2 Nigeria Motion Sickness Treatment Market by Route of Administration
6.4.4.6.3 Nigeria Motion Sickness Treatment Market by Distribution Channel
6.4.4.7 Rest of LAMEA Motion Sickness Treatment Market
6.4.4.7.1 Rest of LAMEA Motion Sickness Treatment Market by Drug Class
6.4.4.7.2 Rest of LAMEA Motion Sickness Treatment Market by Route of Administration
6.4.4.7.3 Rest of LAMEA Motion Sickness Treatment Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Viatris, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental Analysis
7.1.4 Research & Development Expense
7.2 Teva Pharmaceutical Industries Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.3 Amneal Pharmaceuticals, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental Analysis
7.3.4 Research & Development Expenses
7.4 Baxter International, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental Analysis
7.4.4 Research & Development Expense
7.5 Novartis AG
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 Abbott Laboratories
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 SWOT Analysis
7.7 Sun Pharmaceutical Industries Ltd.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 Zydus Lifesciences Ltd.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Trials and Approvals:
7.9 Prestige Consumer Healthcare, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.10. WellSpring Pharmaceutical Corporation (Avista Capital Partners)
7.10.1 Company Overview